Cancer therapy startup Quentis scores VC from Versant Ventures, Polaris Partners
March 01, 2018 at 13:08 PM EST
AbbVie Ventures and Taiho Pharmaceutical also participated in the $48 million round.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.